CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 4.30 million as of July 30, 2025. Its market cap has increased by 265.53% in one year.
Market Cap
4.30M
Enterprise Value
3.01M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.75
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 4.30M, a decrease of -84.78%. That is a compound annual growth rate of -9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 4.30M | 19.51% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | 22.08M | 31.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.32B |
| GSK plc | 56.44B |
| Haleon | 32.70B |
| Smith & Nephew | 10.25B |
| ConvaTec Group | 4.88B |
| Hikma Pharmaceuticals | 4.39B |
| HUTCHMED (China) | 2.25B |
| Oxford Nanopore Technologies | 2.04B |